MISSION & VISION

LEARN MORE
LEADERSHIP
Global leader of expanding the base of pharmacotherapy.
TRAINING AND
EDUCATION
Maximizing the effectiveness of medicines by creating, applying and promoting integrated information and knowledge for personalized pharmacotherapy.
MISSION
Maximizing the effectiveness of medicines by creating, applying and promoting integrated information and knowledge for personalized pharmacotherapy.
CLINICAL TRIALS &
HUMAN PHARMACOLOGY
STUDIES
Undertakes pivotal role of new drug clinical development by giving the global level of consultation and performance about clinical trials.
CLINICAL PRACTICE
Offering patients effective treatments with pharmacotherapeutic consultation based on latest knowledge.

PUBLICATIONS

LEARN MORE
Search
  • 04 Apr
    2026Year
    Population Pharmacokinetic Analysis of MIT-001, a Novel Ferroptosis Inhibitor, for Dose Optimization
  • 03 Mar
    2026Year
    Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)
  • 03 Mar
    2026Year
    Association between body fat percentage and metabolic and hematologic biomarkers in Korean adults
  • 03 Mar
    2026Year
    Exploring LEPR-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese Adults

RESEARCH

LEARN MORE

NEW DRUG
DEVELOPMENT

Clinical trials
Pharmacotherapeutic consultation

OPTIMIZING
PHARMACOTHERAPY

Personalized pharmacotherapy development research
Pharmacometric Research
Real-World data application research
Radioactivity pharmacologic research

HUMAN
PHARMACOLOGY
STUDIES

Pharmacokinetic/Pharmacodynamic research
Drug Omics Research

EDUCATION & TRAINING

LEARN MORE
01UNDERGRADUATE
02GRADUATE
SCHOOL
03RESIDENCY
04INTERNSHIP
05CLINICAL
PHARMACOLOGIST